Published in Am J Hum Genet on March 01, 1995
Genomic features defining exonic variants that modulate splicing. Genome Biol (2010) 1.46
The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. Mol Genet Metab (2012) 1.22
The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. Mol Genet Metab (2011) 1.12
The SR protein SC35 is responsible for aberrant splicing of the E1alpha pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis. Mol Cell Biol (2005) 1.09
Dominant versus recessive: molecular mechanisms in metabolic disease. J Inherit Metab Dis (2008) 0.92
Pyruvate dehydrogenase E1 alpha deficiency: males and females differ yet again. Am J Hum Genet (1995) 0.89
A cognitively normal PDH-deficient 18-year-old man carrying the R263G mutation in the PDHA1 gene. J Inherit Metab Dis (2009) 0.82
An amino acid substitution in the pyruvate dehydrogenase E1 alpha gene, affecting mitochondrial import of the precursor protein. Am J Hum Genet (1995) 0.82
Biochemical and molecular analysis of an X-linked case of Leigh syndrome associated with thiamin-responsive pyruvate dehydrogenase deficiency. J Inherit Metab Dis (1997) 0.82
A case of PDH-E1 alpha mosaicism in a male patient with severe metabolic lactic acidosis. J Inherit Metab Dis (2001) 0.80
MRI features of 4 female patients with pyruvate dehydrogenase E1 alpha deficiency. Pediatr Neurol (2011) 0.76
Pyruvate dehydrogenase E1 alpha deficiency in a family: different clinical presentation in two siblings. J Inherit Metab Dis (1998) 0.76
Capture-based high-coverage NGS: a powerful tool to uncover a wide spectrum of mutation types. Genet Med (2015) 0.75
Clinical manifestations in two patients with pyruvate dehydrogenase deficiency and long-term survival. Hum Genome Var (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
On finding all suboptimal foldings of an RNA molecule. Science (1989) 20.36
Improved predictions of secondary structures for RNA. Proc Natl Acad Sci U S A (1989) 11.52
The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet (1992) 8.20
Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol (1990) 5.35
The skipping of constitutive exons in vivo induced by nonsense mutations. Science (1993) 4.41
Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res (1987) 4.25
Alpha-keto acid dehydrogenase complexes. XI. Comparative studies of regulatory properties of the pyruvate dehydrogenase complexes from kidney, heart, and liver mitochondria. Proc Natl Acad Sci U S A (1969) 3.62
Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet (1991) 3.48
Three-dimensional structure of transketolase, a thiamine diphosphate dependent enzyme, at 2.5 A resolution. EMBO J (1992) 1.87
Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucleic Acids Res (1992) 1.83
Methylation patterns at the hypervariable X-chromosome locus DXS255 (M27 beta): correlation with X-inactivation status. Genomics (1990) 1.57
Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts. J Clin Invest (1981) 1.54
A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. Hum Mol Genet (1993) 1.51
Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex. J Pediatr (1987) 1.41
Differential methylation of the hypervariable locus DXS255 on active and inactive X chromosomes correlates with the expression of a human X-linked gene. Genomics (1990) 1.41
The genetic heterogeneity of lactic acidosis: occurrence of recognizable inborn errors of metabolism in pediatric population with lactic acidosis. Pediatr Res (1980) 1.41
Isolation and characterization of a human variable copy number tandem repeat at Xcen-p11.22. Genomics (1989) 1.37
Isolation of a full-length complementary DNA coding for human E1 alpha subunit of the pyruvate dehydrogenase complex. J Biol Chem (1988) 1.33
The human pyruvate dehydrogenase complex. Isolation of cDNA clones for the E1 alpha subunit, sequence analysis, and characterization of the mRNA. J Biol Chem (1987) 1.31
A nonsense mutation causes hereditary goitre in the Afrikander cattle and unmasks alternative splicing of thyroglobulin transcripts. Proc Natl Acad Sci U S A (1987) 1.26
Regulation of pyruvate oxidation and the conservation of glucose. Biochem Soc Symp (1978) 1.25
Defective gene in lactic acidosis: abnormal pyruvate dehydrogenase E1 alpha-subunit caused by a frame shift. Am J Hum Genet (1989) 1.20
Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients. Hum Mol Genet (1993) 1.16
Structural organization of the gene for the E1 alpha subunit of the human pyruvate dehydrogenase complex. J Biol Chem (1989) 1.12
Pyruvate dehydrogenase deficiency caused by deletion of a 7-bp repeat sequence in the E1 alpha gene. Am J Hum Genet (1990) 1.10
The clinical and biochemical spectrum of human pyruvate dehydrogenase complex deficiency. Ann N Y Acad Sci (1989) 1.07
X chromosome inactivation and the diagnosis of X linked disease in females. J Med Genet (1993) 1.02
Mutations and polymorphisms in the pyruvate dehydrogenase E1 alpha gene. Hum Mutat (1992) 0.98
Isolated and combined deficiencies of the alpha-keto acid dehydrogenase complexes. Ann N Y Acad Sci (1989) 0.95
Defects in the E2 lipoyl transacetylase and the X-lipoyl containing component of the pyruvate dehydrogenase complex in patients with lactic acidemia. J Clin Invest (1990) 0.95
A deficiency of both subunits of pyruvate dehydrogenase which is not expressed in fibroblasts. Pediatr Res (1988) 0.91
The relationships between transketolase, yeast pyruvate decarboxylase and pyruvate dehydrogenase of the pyruvate dehydrogenase complex. FEBS Lett (1993) 0.91
Molecular genetic characterization of an X-linked form of Leigh's syndrome. Ann Neurol (1993) 0.90
Isolation and characterization of mitochondria from human B lymphoblastoid cell lines. Biochem Biophys Res Commun (1992) 0.89
Characterization of the mutations in three patients with pyruvate dehydrogenase E1 alpha deficiency. J Inherit Metab Dis (1991) 0.89
Genetic defects in human pyruvate dehydrogenase. Ann N Y Acad Sci (1989) 0.88
Identification of a novel exonic mutation at -13 from 5' splice site causing exon skipping in a girl with mitochondrial acetoacetyl-coenzyme A thiolase deficiency. J Clin Invest (1994) 0.86
Pyruvate dehydrogenase E1 alpha deficiency. J Inherit Metab Dis (1992) 0.86
Pyruvate dehydrogenase deficiency. Clinical presentation and molecular genetic characterization of five new patients. Brain (1994) 0.85
Characterization of a point mutation in the pyruvate dehydrogenase E1 alpha gene from two boys with primary lactic acidaemia. J Inherit Metab Dis (1994) 0.82
Neurodevelopmental abnormalities and lactic acidosis in a girl with a 20-bp deletion in the X-linked pyruvate dehydrogenase E1 alpha subunit gene. Neurology (1993) 0.80
Mutation of E1 alpha gene in a female patient with pyruvate dehydrogenase deficiency due to rapid degradation of E1 protein. J Inherit Metab Dis (1992) 0.79
Pyruvate dehydrogenase deficiency caused by a 5 base pair duplication in the E1 alpha subunit. Hum Mol Genet (1993) 0.79
Pyruvate dehydrogenase deficiency due to a 20-bp deletion in exon II of the pyruvate dehydrogenase (PDH) E1 alpha gene. Am J Hum Genet (1991) 0.79
A four-nucleotide insertion at the E1 alpha gene in a patient with pyruvate dehydrogenase deficiency. J Inherit Metab Dis (1991) 0.79
Pyruvate dehydrogenase deficiency in a male caused by a point mutation (F205L) in the E1 alpha subunit. Hum Mutat (1994) 0.79
A four-nucleotide insertion hotspot in the X chromosome located pyruvate dehydrogenase E1 alpha gene (PDHA1). Hum Mol Genet (1993) 0.79
A mutation in the E1 alpha subunit of pyruvate dehydrogenase associated with variable expression of pyruvate dehydrogenase complex deficiency. Pediatr Res (1992) 0.78
Pyruvate dehydrogenase deficiency due to a mutation of the E1 alpha subunit. J Inherit Metab Dis (1991) 0.78
Pyruvate dehydrogenase deficiency caused by a 33 base pair duplication in the PDH E1 alpha subunit. Hum Mol Genet (1994) 0.78
Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature (1991) 10.30
Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature (1984) 6.54
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet (2001) 5.08
Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature (1986) 4.73
Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol (1993) 4.05
Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev (1989) 3.87
Lactic acidemia and bradyarrhythmia in a child sedated with propofol. Crit Care Med (1998) 3.71
Approaches to DNA mutagenesis: an overview. Anal Biochem (1997) 3.09
Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci (2000) 3.04
A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med (1992) 2.86
Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr (1998) 2.72
The inhibition of malate, tricarboxylate and oxoglutarate entry into mitochondria by 2-n-butylmalonate. Biochem Biophys Res Commun (1967) 2.64
Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol (2001) 2.41
Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet (1992) 2.41
Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology (2000) 2.34
Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr (2001) 2.22
Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest (1996) 2.20
Encoding of anisotropic diffusion with tetrahedral gradients: a general mathematical diffusion formalism and experimental results. Magn Reson Med (1996) 2.20
Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol (2001) 2.12
Meiotic drive at the myotonic dystrophy locus? Nat Genet (1994) 2.08
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Aliment Pharmacol Ther (2015) 1.99
Penetration of the mitochondrial membrane by glutamate and aspartate. Biochem Biophys Res Commun (1967) 1.99
Epstein-Barr virus recombinants from overlapping cosmid fragments. J Virol (1993) 1.97
Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology (2003) 1.94
Penetration of the mitochondrial membrane by tricarboxylic acid anions. Biochem Soc Symp (1968) 1.91
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet (1998) 1.88
A rapid and reliable DNA preparation method for screening a large number of yeast clones by polymerase chain reaction. Nucleic Acids Res (1995) 1.84
XY female mice resulting from a heritable mutation in the primary testis-determining gene, Tdy. Development (1990) 1.83
MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett (2000) 1.82
A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci U S A (1988) 1.80
Nonviability of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts. Biochem Med Metab Biol (1992) 1.75
Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci (2006) 1.75
Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat (2000) 1.75
Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians. Am J Hum Genet (1996) 1.68
The sensitivity of dicarboxylate anion exchange reactions o transport inhibitors in rat-liver mitochondria. Biochim Biophys Acta (1970) 1.62
Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet (2001) 1.61
Requests for electromyography from general practitioners and specialists: critical evaluation. Ital J Neurol Sci (1998) 1.59
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology (2009) 1.59
Selection for developmental canalisation. Genet Res (1966) 1.58
Reverse micelles as hosts for proteins and small molecules. Biochim Biophys Acta (1988) 1.58
A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec. Am J Hum Genet (1993) 1.57
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56
Cerebrotendinous xanthomatosis with predominant parkinsonian syndrome: further confirmation of the clinical heterogeneity. Mov Disord (2000) 1.53
Cancer in patients receiving dialysis. Br Med J (1980) 1.52
Psychological impact of screening for familial ovarian cancer: reactions to initial assessment. Gynecol Oncol (1997) 1.50
Magnesium transport in the renal distal convoluted tubule. Physiol Rev (2001) 1.44
CSF levels of beta-amyloid 1-42, tau and phosphorylated tau protein in CADASIL. Eur J Neurol (2008) 1.44
Late diagnosis in severe and mild intellectual disability in adulthood. J Intellect Disabil Res (2004) 1.43
The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci U S A (1998) 1.43
Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex. J Pediatr (1987) 1.41
The genetic heterogeneity of lactic acidosis: occurrence of recognizable inborn errors of metabolism in pediatric population with lactic acidosis. Pediatr Res (1980) 1.41
Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean. Am J Hum Genet (1993) 1.40
Neuropaediatrics. Childs Nerv Syst (1995) 1.40
Isolation and sequence determination of cDNA clones for porcine and human lipoamide dehydrogenase. Homology to other disulfide oxidoreductases. J Biol Chem (1987) 1.40
Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol (2007) 1.39
High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet (1999) 1.38
Superoxides from mitochondrial complex III: the role of manganese superoxide dismutase. Free Radic Biol Med (2000) 1.37
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology (2004) 1.36
Isolation of a full-length complementary DNA coding for human E1 alpha subunit of the pyruvate dehydrogenase complex. J Biol Chem (1988) 1.33
Barth syndrome: clinical observations and genetic linkage studies. Am J Med Genet (1994) 1.31
An analysis of the reflex systemic vasodilator response elicited by lung inflation in the dog. J Physiol (1968) 1.29
Expression of mtDNA and nDNA encoded respiratory chain proteins in chemically and genetically-derived Rho0 human fibroblasts: a comparison of subunit proteins in normal fibroblasts treated with ethidium bromide and fibroblasts from a patient with mtDNA depletion syndrome. Biochim Biophys Acta (1997) 1.29
[3H]biotin-labeled proteins in cultured human skin fibroblasts from patients with pyruvate carboxylase deficiency. J Biol Chem (1983) 1.27
Familial Hibernian fever. Q J Med (1982) 1.26
Novel SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay type. Neurology (2004) 1.26
Iron metabolism in the anaemia of chronic renal failure. Effects of dialysis and of parenteral iron. Br Med J (1969) 1.26
Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res (1999) 1.25
The use of skin fibroblast cultures in the detection of respiratory chain defects in patients with lacticacidemia. Pediatr Res (1990) 1.23
Site-specific incorporation of nitroxide spin-labels into internal sites of the TAR RNA; structure-dependent dynamics of RNA by EPR spectroscopy. J Am Chem Soc (2001) 1.23
Agonal phase, ischaemic times, and renal vascular abnormalities and outcome of cadaver kidney transplants. Br Med J (1975) 1.22
A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. Am J Hum Genet (2001) 1.22
Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol Sci (2010) 1.22
Spatial and temporal distribution of the neutral polymorphisms in the last ZFX intron: analysis of the haplotype structure and genealogy. Genetics (1999) 1.21
Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain (2001) 1.21
Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology (2001) 1.20
Motions of short DNA duplexes: an analysis of DNA dynamics using an EPR-active probe. Biochemistry (1993) 1.20
The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry (2005) 1.19
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology (2008) 1.19
Interfacial membrane docking of cytosolic phospholipase A2 C2 domain using electrostatic potential-modulated spin relaxation magnetic resonance. Proc Natl Acad Sci U S A (1999) 1.18
Sequence-dependent dynamics of duplex DNA: the applicability of a dinucleotide model. Biophys J (2002) 1.18
Transport of reduced nicotinamide-adenine dinucleotide into mitochondria of rat white adipose tissue. Biochem J (1970) 1.17
The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria. Biochem Biophys Res Commun (1993) 1.16
Sequence- and structure-dependent DNA base dynamics: synthesis, structure, and dynamics of site and sequence specifically spin-labeled DNA. Biochemistry (1989) 1.16
Analysis of double-helix motions with spin-labeled probes: binding geometry and the limit of torsional elasticity. J Mol Biol (1980) 1.16
X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. J Clin Endocrinol Metab (1981) 1.15
Simultaneous detection of mitochondrial respiratory chain activity and reactive oxygen in digitonin-permeabilized cells using flow cytometry. Cytometry (2000) 1.14
Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat (2000) 1.14
Lenz microphthalmia: a malformation syndrome with variable expression of multiple congenital anomalies. Can J Ophthalmol (1983) 1.13
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2005) 1.13
Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest (1994) 1.13
Differential structuring of human populations for homologous X and Y microsatellite loci. Am J Hum Genet (1997) 1.12
A genomewide linkage-disequilibrium scan localizes the Saguenay-Lac-Saint-Jean cytochrome oxidase deficiency to 2p16. Am J Hum Genet (2001) 1.12
The molecular basis for the two different clinical presentations of classical pyruvate carboxylase deficiency. Am J Hum Genet (1984) 1.12
The effects of graded doses of phenoxybenzamine on the vascular and capsular responses of the isolated, blood-perfused dogs spleen to sympathetic nerve stimulation and catecholamines. Arch Int Pharmacodyn Ther (1969) 1.12
An Ontario-wide study of vitamin B12, serum folate, and red cell folate levels in relation to plasma homocysteine: is a preventable public health issue on the rise?. Clin Biochem (2000) 1.12